<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000630936">
  <TermName>CRA-024781</TermName>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor. </DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>CRA-024781</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de varios tipos de cáncer. Bloquea enzimas necesarias para la división celular y es posible que destruya células cancerosas. Es un tipo de inhibidor de la histona–desacetilasa (HDAC).</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-02-19</DateFirstPublished>
</GlossaryTerm>
